An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment.

Zhou, Yuan; Tang, Lu; Chen, Yuqiao; Zhang, Youyu; Zhuang, Wei

Zhou, Yuan; Tang, Lu; Chen, Yuqiao; Zhang, Youyu; Zhuang, Wei.

Afiliación

Zhou Y; Department of Thoracic Surgery, Xiangya Hospital of Central South University, Changsha, China.
Tang L; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Changsha, China.
Chen Y; Department of Anesthesiology, Xiangya Hospital of Central South University, Changsha, China.
Zhang Y; Department of Thoracic Surgery, Xiangya Hospital of Central South University, Changsha, China.
Zhuang W; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Changsha, China.

Front Cell Dev Biol ; 9: 797984, 2021.

Article en En | MEDLINE | ID: mdl-34993203

Palabras clave

gene signature; immune panel sequencing; lung adenocarcinoma; metastasis; progression-free survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google